Literature DB >> 28914361

In reply: Sevoflurane in patients at risk of ventricular dysrhythmias.

Yoshiaki Terao1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28914361     DOI： 10.1007/s00540-017-2405-4

Source DB:  PubMed          Journal:  J Anesth        ISSN： 0913-8668            Impact factor:   2.078


× No keyword cloud information.
  5 in total

1.  Sevoflurane in patients at risk of ventricular dysrhythmias.

Authors:  Beny Charbit
Journal:  J Anesth       Date:  2017-04-01       Impact factor: 2.078

2.  Mechanisms underlying the QT interval-prolonging effects of sevoflurane and its interactions with other QT-prolonging drugs.

Authors:  Jiesheng Kang; William P Reynolds; Xiao-Liang Chen; Junzhi Ji; Hongge Wang; David E Rampe
Journal:  Anesthesiology       Date:  2006-05       Impact factor: 7.892

Review 3.  Propofol and arrhythmias: two sides of the coin.

Authors:  Qiang Liu; Ai-ling Kong; Rong Chen; Cheng Qian; Shao-wen Liu; Bao-gui Sun; Le-xin Wang; Long-sheng Song; Jiang Hong
Journal:  Acta Pharmacol Sin       Date:  2011-06       Impact factor: 6.150

4.  Modeling the effect of sevoflurane on corrected QT prolongation: a pharmacodynamic analysis.

Authors:  Dong Woo Han; Kyungsoo Park; Seong Bok Jang; Steven E Kern
Journal:  Anesthesiology       Date:  2010-10       Impact factor: 7.892

5.  The effects of intravenous anesthetics on QT interval during anesthetic induction with sevoflurane.

Authors:  Yoshiaki Terao; Ushio Higashijima; Tomomi Toyoda; Taiga Ichinomiya; Makoto Fukusaki; Tetsuya Hara
Journal:  J Anesth       Date:  2016-09-21       Impact factor: 2.078
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.